Koor, the giant Histadrut company, has announced that its subsidiary, Koor Intertrade-America, which introduces Israeli products to the United States, is expected to earn $100 million this year. Its turnover last year was $84 million. Koor also said that its pharmaceutical company Plantex, has received American approval to export $4.5 million of new drugs to the United States, including medicine for heart treatment, anti-inflammation and Parkinson’s Disease. The company’s total exports to the U.S. is expected to reach $50 million in 1977. Koor Intertrade-Europe has also been selected by the International Telephone and Telegraph Co. to market in Europe electronic devices produced by ITT’s subsidiary.
Help ensure Jewish news remains accessible to all. Your donation to the Jewish Telegraphic Agency powers the trusted journalism that has connected Jewish communities worldwide for more than 100 years. With your help, JTA can continue to deliver vital news and insights. Donate today.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
